The Company

It all began in 1983 in the city of Serres, Greece, when two pharmacists with operating pharmacies founded Mediplants. Their aim was to research and cultivate aromatic medicinal plants and to process these plants for producing raw materials necessary for the preparation of galenic formulations.

Focusing on meeting the requirements of pharmacy laboratories and the potential offered by producing galenic formulations, one of the company’s first activities included repackaging and standardizing pharmaceutical raw materials (active and non-active). This led to the establishment of a laboratory, approved by the National Organization for Medicines (EOF), for the production of pharmaceutical and cosmetic products.

The company introduced essential galenic formulations to the market (such as hydrogen peroxide solution, iodine tincture, mercurochrome, glycerin enemas and corn removing liquid). Finally, Mediplants released Oinopneuma Farmaceutico, the first ethanol solution 70% for exclusive sale in pharmacies.

01

1983

The need to create an in-house laboratory that extends the boundaries of the pharmacy led to the establishment of Mediplants. The name—a combination of the words Medicinal and Plants—stems from the original idea: the cultivation, processing, and standardization of aromatic medicinal plants and their products (e.g., tinctures, essential oils).After the company was established, its first activity was collecting and selling medicinal plants (e.g., chamomile and sage) in collaboration with growers.

01

1984

This is the year Mediplants’ first product, clove oil, was standardized and has been marketed steadily since then.

01

1992

The company moves to new premises.

01

1993

By a joint ministerial decision of the Ministers of Health and Industry, the Mediplants laboratory is granted a license to manufacture Pharmaceutical and Cosmetic Products in addition to its other activities.

01

2003

Oinopneuma Farmaceutico Mediplants (Ethanol) 70%v/v is released with a Non-Prescription Drug license from the National Organization for Medicines.

01

2010

The National Organization for Medicines issued a certificate of compliance with Good Manufacturing Practice (GMP) standards to Mediplants’ pharmaceutical laboratory.

NEW GENERATION

Vision

We aim to continue to offer safe products of high standards while maintaining our company’s quality principles.

Evolution

We are committed to continuously improving our products and services and developing new ones adapted to the needs of the modern pharmacy.

Principles

Mediplants Pharmaceutical Laboratory produces most of its products on its premises, handling the entire production process from raw materials to distribution to pharmacies and hospitals.

With an eye to the future

The company operates with a commitment to the pharmacy laboratory’s production of structural, essential pharmacopeia formulations. We are breaking new ground and strengthening the pharmacist’s role as a competent professional for general and special cases.

Mediplants has a Good Manufacturing Practice (GMP) compliance certification from the National Organization for Medicines.

ΣΥΝΕΡΓΑΤΕΣ

Εταιρική κοινωνική ευθύνη

Environment

Mediplants follows the applicable national environmental legislative requirements for protecting the environment and maintains contracts with specialized partners for packaging recycling and the recovery and management of production waste. Each of us operates based on minimizing environmental impact and rational management of natural resources.